Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial December 1, 2017 by Daniel M. Siegel, MD; Stephen Tyring, MD, PhD; Walter K. Nahm, CONTINUE READING »
Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial November 1, 2017 by Brian Berman, MD, PhD; Stephen Tyring, MD, PhD; Walter K. Nahm, CONTINUE READING »
